From Bangladesh to Melbourne …… via Perth
By Karen Loudon / March 25, 2019
Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC)...
Read More
Australia is handicapped in the delivery of cell therapies, says Alan Trounson
By Karen Loudon / March 21, 2019
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer...
Read More
Safer cells for immunotherapy
By Karen Loudon / February 13, 2019
Cartherics Pty Ltd teams up with Canada's panCELLa Inc to bring the power of safe cell therapy to a greater...
Read More
Eradicate Cancer 2020 – Next frontiers in immunotherapy
By Karen Loudon / January 29, 2019
Melbourne Convention and Exhibition Centre, 25-27 March 2020 "Success Breeds Success" The field of immunotherapy against cancers is making unprecedented...
Read More
Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies
By Karen Loudon / January 23, 2019
BD Biotech Daily Jan 23 - Cartherics
Read More
SUPER-CHARGING THE IMMUNE SYSTEM TO FIGHT CANCER
By Karen Loudon / January 21, 2019
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and...
Read More
New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories
By Karen Loudon / December 20, 2018
https://www.eurekalert.org/pub_releases/2018-12/uoc--nci120418.php In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells...
Read More
‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)
By Karen Loudon / December 19, 2018
Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html A revolutionary cancer therapy that supercharges a patient's...
Read More
Meet our newest recruit
By Karen Loudon / December 18, 2018
Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal. I’ve always had...
Read More
Come Hell Or High Water
By Karen Loudon / December 4, 2018
Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good...
Read More
The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System
By Karen Loudon / November 29, 2018
An interview with UK immunologist Daniel Davis on national Public Radio's "Fresh Air" is a good discussion about his new...
Read More
Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’
By Karen Loudon / November 22, 2018
WHAT PISSES ME OFF When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos...
Read More
Communications Adviser Leigh Dayton talks to Cartherics Scientific Board member Jacques Miller – the man who discovered the function of the thymus gland yet didn’t win the Nobel Prize.
By Karen Loudon / November 9, 2018
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year...
Read More
Communications Adviser Leigh Dayton talked with cancer immunologist Ashleigh Unsworth
By carth_admin / October 15, 2018
WELCOME to The Pipeline, the place where Cartherics team members share occasional news and views. To get things rolling, Communications...
Read More
Today interview : Greg Hunt and Georgie Gardner
By Karen Loudon / October 15, 2018
Health Minister Greg Hunt promotes the prospects for immunotherapy on The Today Show 12 October 2018
Read More
